Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  indium In 111 pentetreotide
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-3 of 3 for your search:
Start Over
Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors
Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 092/11, NCT02078843
TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BRD 11/5-K, NCT01747096
Gallium Ga 68-Edotreotide PET/CT Compared With Indium In 111 Pentetreotide Plus Contrast-Enhanced CT (or MRI) in Diagnosing Patients With Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: 201212736, NCI-2013-00936, P30CA086862, R01CA167632, NCT01869725
Start Over